BCL2A1 and infection: As for some DZ signature genes, the LZ biomarker CD83 is downregulated upon infection in ensemble experiments but retained in EBV+ subsets co-expressing BCL2A1 (BFL-1) and other GC LZ hallmarks (CD80, CD86, and MYC) (61, 62).